0001415889-24-018977.txt : 20240702
0001415889-24-018977.hdr.sgml : 20240702
20240702173150
ACCESSION NUMBER: 0001415889-24-018977
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240701
FILED AS OF DATE: 20240702
DATE AS OF CHANGE: 20240702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DIORIO CHRIS PH.D.
CENTRAL INDEX KEY: 0001677721
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37824
FILM NUMBER: 241097251
MAIL ADDRESS:
STREET 1: 400 FAIRVIEW AVENUE NORTH
STREET 2: SUITE 1200
CITY: SEATTLE
STATE: WA
ZIP: 98109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMPINJ INC
CENTRAL INDEX KEY: 0001114995
STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPONENTS, NEC [3679]
ORGANIZATION NAME: 04 Manufacturing
IRS NUMBER: 912041398
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 FAIRVIEW AVENUE NORTH
STREET 2: SUITE 1200
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-517-5300
MAIL ADDRESS:
STREET 1: 400 FAIRVIEW AVENUE NORTH
STREET 2: SUITE 1200
CITY: SEATTLE
STATE: WA
ZIP: 98109
4
1
form4-07022024_090747.xml
X0508
4
2024-07-01
0001114995
IMPINJ INC
PI
0001677721
DIORIO CHRIS PH.D.
400 FAIRVIEW AVENUE NORTH
SUITE 1200
SEATTLE
WA
98109
true
true
false
false
CHIEF EXECUTIVE OFFICER
1
Common Stock
2024-07-01
4
M
0
5000
22.40
A
294474
D
Common Stock
2024-07-01
4
S
0
889
151.4035
D
293585
D
Common Stock
2024-07-01
4
S
0
392
152.2533
D
293193
D
Common Stock
2024-07-01
4
S
0
1385
153.3735
D
291808
D
Common Stock
2024-07-01
4
S
0
409
154.6645
D
291399
D
Common Stock
2024-07-01
4
S
0
1093
155.554
D
290306
D
Common Stock
2024-07-01
4
S
0
832
156.4343
D
289474
D
Common Stock
2024-07-02
4
M
0
5000
22.40
A
294474
D
Common Stock
2024-07-02
4
S
0
1083
154.5485
D
293391
D
Common Stock
2024-07-02
4
S
0
3567
155.6878
D
289824
D
Common Stock
2024-07-02
4
S
0
350
156.34
D
289474
D
Common Stock
552494
I
by DFT L.L.C.
Stock Option (right to buy)
22.40
2024-07-01
4
M
0
5000
0
D
2028-06-15
Common Stock
5000
85536
D
Stock Option (right to buy)
22.40
2024-07-02
4
M
0
5000
0
D
2028-06-15
Common Stock
5000
80536
D
The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan effective on February 28, 2024.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $150.84 to $151.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $151.975 to $152.855, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $153.045 to $153.905, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $154.09 to $154.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $155.265 to $156.025, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $156.32 to $156.6775, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $154.25 to $155.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $155.25 to $156.245, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
The option became fully vested on June 11, 2022.
/s/ Yukio Morikubo, Attorney in fact for Chris Diorio
2024-07-02